Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.
Level 5 - mechanism / opinion, no new human data
Preclinical bench and animal research without human subjects.
PubMed 24226770 · doi:10.1038/nature12721
What was done
Researchers investigated how gut microbiota induce colonic regulatory T (Treg) cells using mouse models and cell culture. They used NMR-based metabolomics to examine the relationship between luminal short-chain fatty acids (SCFAs) and colonic Treg counts. They tested the effects of butyrate on Treg differentiation in vitro and in vivo, assessed its impact on colitis induced by adoptive transfer of CD4+ CD45RB(hi) T cells into Rag1-/- mice, and measured histone H3 acetylation at the promoter and conserved non-coding sequence regions of the Foxp3 locus under Treg-polarizing conditions.
What was found
The abstract reports no numerical values or effect sizes. Directionally, luminal SCFA concentrations positively correlated with colonic Treg numbers. Butyrate specifically induced Treg differentiation in vitro and in vivo, reduced the development of adoptive transfer colitis in Rag1-/- mice, and enhanced histone H3 acetylation at the Foxp3 promoter and conserved non-coding sequences.
Why it matters
This study provides an epigenetic mechanism by which commensal microbial metabolites promote mucosal immune homeostasis, showing that butyrate enhances Foxp3 acetylation and regulatory T-cell differentiation to limit intestinal inflammation.
Limits
The experiments were conducted exclusively in cell cultures and mouse models; direct translation to human mucosal immunology is unproven. The abstract lacks sample sizes, effect magnitudes, and statistical metrics. Potential off-target effects of systemic SCFA modulation were not described in the abstract.
Cited by
- supports Short-chain fatty acids produced by gut bacteria fermentation, including acetate, butyrate, and propionate, increase the number of regulatory T cells to modulate autoimmune responses.